Shop

Rybelsus® 3 mg is the starting dose of oral semaglutide, a once-daily GLP-1 receptor agonist used to help adults with type 2 diabetes control their blood sugar levels. It mimics the natural gut hormone GLP-1, enhancing insulin secretion and reducing blood sugar in a glucose-dependent manner. While this dose is not intended for long-term glycemic control, it plays a crucial role in allowing the body to gradually adjust to semaglutide before increasing to therapeutic doses (7 mg or 14 mg).  

• Product Name: Rybelsus®

• Generic Name: Semaglutide Tablets 3 mg

• Strength: 3 mg per tablet

• Quantity: 10 tablets per pack

• Form: Oral tablet (film-coated)

• Packaging Type:

  • Primary: Blister strip

  • Secondary: Printed carton box containing blister(s) and patient information leaflet (PIL)

Brand Name: Sustaviron 250 Injection
Generic Name: Testosterone Propionate, Phenylpropionate, Isocaproate, and Decanoate
Manufacturer: Searle
Strength: 250 mg/ml
Packaging: 1 Ampoule with Disposable Syringe
Approx. Price: $ — / Piece
Category: Testosterone Replacement Therapy / Hormone Injection

Generic Name

Mebendazole

Strength

500 mg

Dosage Form

Tablet

Category

Anthelmintic / Anti-Worm Medication

Prescription Required

Yes (Rx)

Pack Type

Strip / Box

Rybelsus® 7 mg is an oral GLP-1 receptor agonist containing semaglutide, designed to help adults with type 2 diabetes manage their blood sugar levels effectively. As an intermediate-strength dose, it is commonly used after initial dose titration and provides significant benefits in glycemic control while also supporting weight loss by reducing appetite and slowing digestion. Rybelsus 7 mg offers a convenient, once-daily, non-injectable option for patients seeking improved metabolic health and body weight regulation as part of a comprehensive diabetes care plan.

Packaging Information

• Product Name: Rybelsus®

• Generic Name: Semaglutide Tablets 7 mg

• Strength: 7 mg per tablet

• Quantity: 10 tablets per pack

• Form: Oral tablet (film-coated)

• Tablet Appearance: Oval, light orange, debossed with tablet strength

• Packaging Type:

  • Primary: Blister strip

  • Secondary: Printed carton box containing blister(s) and patient information leaflet (PIL)